Anticholinergic drug useful in treatment of peptic ulcer disease is
## **Core Concept**
Anticholinergic drugs, also known as antimuscarinics, are used to reduce gastric acid secretion by blocking the action of acetylcholine at muscarinic receptors in the stomach. This class of drugs can be useful in the treatment of peptic ulcer disease by decreasing acid production.
## **Why the Correct Answer is Right**
The correct answer, Pirenzepine, is a selective M1 muscarinic receptor antagonist. M1 receptors are primarily found in the gastric parietal cells and are involved in the regulation of gastric acid secretion. By selectively blocking M1 receptors, pirenzepine reduces gastric acid secretion without causing significant side effects associated with non-selective anticholinergic drugs. This makes pirenzepine particularly useful in the treatment of peptic ulcer disease.
## **Why Each Wrong Option is Incorrect**
* **Option A:** Atropine is a non-selective muscarinic receptor antagonist that blocks all types of muscarinic receptors. While it can reduce gastric acid secretion, its lack of specificity leads to a wide range of side effects, making it less ideal for the treatment of peptic ulcer disease compared to selective agents like pirenzepine.
* **Option B:** Propantheline is another non-selective anticholinergic drug. Like atropine, it has a broad range of effects on muscarinic receptors, which can lead to significant side effects and makes it less suitable for long-term management of peptic ulcer disease.
* **Option D:** Methantheline is also a non-selective muscarinic receptor antagonist. It has been used for gastrointestinal disorders but, similar to atropine and propantheline, its non-selective action results in side effects that limit its use in peptic ulcer disease.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while anticholinergic drugs can be effective in treating peptic ulcer disease by reducing gastric acid secretion, their use has declined with the advent of more targeted therapies like proton pump inhibitors (PPIs) and H2 receptor antagonists, which have better efficacy and safety profiles. However, selective M1 muscarinic receptor antagonists like pirenzepine offer a more targeted approach with potentially fewer side effects.
## **Correct Answer:** . Pirenzepine